FOLH1 and posterior cortical atrophy: Prostate-specific membrane antigen (PSMA) positron emission tomography / computed tomography (PET/CT) is increasingly being used for initial staging of patients with intermediate and high-risk primary PCa as well as in patients with recurrent disease after treatment with curative intent [5–7].